NPI: 1427090828 · LAS VEGAS, NV 89119 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 26,687 | $443K |
| 2019 | 35,745 | $497K |
| 2020 | 30,762 | $456K |
| 2021 | 33,549 | $412K |
| 2022 | 32,652 | $557K |
| 2023 | 16,845 | $585K |
| 2024 | 4,177 | $494K |
| Code | Description | Claims | Bene. Records | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 60,850 | 2,692 | $3.44M |
| G0008 | Administration of influenza virus vaccine | 114 | 57 | $547.25 |
| 85048 | 3,332 | 1,316 | $0.00 | |
| 85041 | 3,393 | 1,333 | $0.00 | |
| 83540 | 3,468 | 1,354 | $0.00 | |
| 83970 | 2,561 | 942 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 904 | 138 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 9,826 | 1,354 | $0.00 |
| 82108 | 221 | 100 | $0.00 | |
| 90661 | 15 | 13 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 4,891 | 1,568 | $0.00 |
| 82728 | 3,328 | 1,336 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 420 | 179 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 28,134 | 1,338 | $0.00 |
| 83550 | 2,367 | 1,133 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 506 | 134 | $0.00 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 55,974 | 1,582 | $0.00 |
| 90674 | 69 | 40 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 44 | 24 | $0.00 |